Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Autism Spectrum Disorders Market size was over USD 8.5 billion in 2024 and is estimated to reach USD 18.8 billion by the end of 2037, expanding at a CAGR of 7.1% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of autism spectrum disorders is assessed at USD 9.1 billion.
The growing incidences of autism spectrum disorders (ASDs) around the world, particularly in developed nations, are pushing healthcare systems to accommodate advanced diagnostic and treatment solutions. In this regard, the WHO reported that the global occurrence rate of this ailment is 1.3%. On the other hand, the Robert Koch Institute (RKI) also highlighted a 40.2% rise in ASD incidences in Germany alone in 2025 from 2018, accounting for 800,010. Additionally, advancements and improvements in screening practices have significantly propelled the volume of this demographic expansion. As a result, it reflects a sustainable demand in the market.
Despite the growing awareness, the wide adoption in the market is still restricted by the trend of premium pricing for branded commodities. This is primarily attributable to the consistent inflation in the key economic indicators, such as payers' pricing. Testifying this, in 2024, the Bureau of Labor Statistics (BLS) recorded a 4.3% year-over-year (YoY) rise in the producer price index (PPI) for ASD-related medicines, as a result of supply chain disruptions and increased cost of extensive R&D. Subsequently, this flow is further followed by the 5.2% growth in the consumer price index (CPI) for behavioral interventions and treatment services in 2024. In response, the sector is raising government funds and subsidiary policies to minimize the financial disparity and exhaustion.
